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http://dx.doi.org/10.1016/j.bgm.201Abstract Colorectal cancer (CRC) has a high metastasis rate. MicroRNA (miRNA) is an epige-
netic factor required to regulate cell proliferation, tumor cell growth, cancer formation, and
metastasis by regulating tumor-suppressor genes or oncogenes. The objective of this study is to
identify miRNAs and their target genes related to CRC migration and metastasis. Previously, we
used miRNA microarray to reveal that miR-338-5p was significantly upregulated in patients
with recurrent CRC. The expression level of miR-338-5p in tumor tissues of metastatic patients
is higher than that in nonmetastatic patients. In this study, we report that miR-338-5p expres-
sion level was positively correlated with high migration activity of CRC cells. Overexpression ofof Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 70101,
of Surgery, Chi Mei Medical Center, 901 Chang Hwa Road, Yongkang Dist., Tainan 710, Taiwan.
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Colorectal cancer migration and autophagy-related microRNA 75miR-338-5p induced the migration of CRC HCT-116 cells. Furthermore, overexpression of miR-
338-5p inhibited its target gene phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3)
messenger RNA (mRNA) and protein expression in HCT-116 cells. Downregulation of miR-338-5p
increased PIK3C3 mRNA and protein expression in CRC SW480 cells. Furthermore, our study re-
sults show that miR-338-5p blocked autophagy, as demonstrated by decreased LC3 type II
expression. Autophagy inhibited the migration of colon cancer cell HCT-116 after rapamycin
treatment. It can thus be concluded that miR-338-5p induces CRC cell migration by suppressing
PIK3C3 expression and autophagy.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Colorectal cancer (CRC) has higher recurrence and metas-
tasis rate. Approximately 25e30% of patients with stage II
CRC undergo surgery with recurrence. Furthermore, some
patients with stage III cancer receive chemical therapy that
is inefficient.1 This trend indicates that the traditional
pathologic classification based on stages is not sufficient.
Therefore, there is an urgent need to establish a new
diagnosis and prognosis tool for patients with colon cancer.
Unfortunately, effective molecular biomarkers for diag-
nosing colon cancer are still unavailable.
MicroRNA (miRNA) is an epigenetic factor that is respon-
sible for cell proliferation, tumor cell growth, cancer forma-
tion, and metastasis by regulating tumor-suppressor genes or
oncogenes.2e5 Therefore, miRNA has the potential to be a
biomarker for diagnosing CRC. miRNA miR-338 is a family of
brain-specific miRNA precursors, located in an intronic region
within the gene for apoptosis-associated tyrosine kinase
(AATK).6 miR-338 is downregulated in hepatocellular carci-
noma.7 In ourprevious study,we reported that themiR-338-5p
expression is highly expressed in metastatic CRC tumor tis-
sues.8 By contrast, the expression of miR-338-5p is relatively
low in the circulating blood of early-stage CRC patients.9
Therefore, the role of miR-338-5p in CRC remains unclear.
Autophagy is associated with many diseases, including
cancers. Many studies have shown that autophagy can block
tumor genesis, whereas others have reported that auto-
phagy can induce tumor formation.10e12 Our study predicts
that the miR-338-5p target gene is phosphatidylinositol 3-
kinase catalytic subunit type 3 (PIK3C3). Moreover, PIK3C3
can regulate the autophagy pathway by forming complexes
with beclin-1, Atg14, and UVRAG.13 Thus, inducing auto-
phagy by beclin-1 overexpression can block cervical cancer
migration.14 Because miR-338-5p is related to CRC metas-
tasis, in this study, we further revealed the role of miR-338-
5p in cancer cell migration and autophagy, which may
participate in metastasis of CRC.Materials and methods
Cell lines
Thecolon cancer cell lines SW480, SW620,HCT-116, andHT29
were used for validation (American Type Culture Collection;
Rockville, MD, USA). The colon cancer cell lines SW480 andSW620 were cultured with L15 containing 10% fetal bovine
serum (FBS; Invitrogen, CA, USA); HCT-116 and HT29 were
cultured with Dulbecco’s modified Eagle medium containing
10% FBS (Invitrogen) at 37 C in a 5% CO2 incubator.
Tumor tissues
Fifty-one paired CRC specimens (tumor and adjacent
normal tissues), which include Dukes stage AeD CRC spec-
imens (Stage A: 3; Stage B: 12; Stage C: 19; and Stage D:
17), were collected from the National Cheng Kung Univer-
sity (NCKU) Hospital, Tainan, Taiwan. Informed consents
were obtained from the patients and the study protocol was
approved by the Institutional Review Board of the NCKU
Hospital (Tainan, Taiwan).
RNA extraction, reverse transcription, and real-
time polymerase chain reaction
The RNA of the specimens and cell lines were extracted
using TRIzol reagent (MDBio Inc., Taipei, Taiwan). The
miRNA reverse transcription method was performed using
the NCode VILO miRNA complementary DNA synthesis kit
(Invitrogen), and the products were incubated at 37 C for
60 minutes. The expression of miR-338-5p and PIK3C3
messenger RNA (mRNA) was measured using SYBR Green
SuperMix (Applied Biosystems, Birchwood, Cheshire, UK) by
real-time polymerase chain reaction.
Migration assay
The migration of colon cancer cell was evaluated by wound-
healing analysis and electric cell-substrate impedance-
sensing (ECIS) electric wound-healing analysis. In the ECIS
assay, cells were wounded with a voltage pulse of 48,000-
Hz frequency by passing 1400-mA current for 20 seconds
(Applied BioPhysics, Troy, NY, USA). The impedance value
was measured prior to and after wound healing, and
stopped at 24 hours.
3-(4,5-Cimethylthiazol-2-yl)-2,5-diphenyltetra
zolium bromide assay
The cells were plated in 96-well plates at a density of 4000/
well and cultured for 24 hours, 48 hours, 72 hours, and 96
hours. Cell proliferation was measured every 24 hours by 3-
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30-UTR Z 30-untranslated region; CRC Z colorectal cancer;
mRNA Z messenger RNA; PIK3C3 Z phosphatidylinositol 3-
kinase catalytic subunit type 3.
*p value was calculated by t test.
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(MTT) assay (Sigma, St. Louis, USA; M2128).
Luciferase (Luc) assay
To determine whether PIK3C3 is a direct target of miR-338-
5, we cloned the miR-338-5p-predicted target sequence
that is contained within its 30-untranslated region (30-UTR)
downstream of a luciferase gene in the p-miR-reporter
luciferase plasmid (Ambion Inc., Austin, USA). The lysate
was assayed by the Dual-Glo luciferase assay system
(E1960; Promega, Madison, WI, USA) and was measured by a
luminometer (EG&G Berthold, Wildbad, Germany).
Western blot analysis
The protein expression of PIK3C3 and LC3 was measured by
Western blot analysis. The antibodies used were mono-
clonal antibodies for b-actin (A5441; Sigma), LC3 (PM036;
MBL, Nagoya, Japan), and PIK3C3 (#4263, cell signaling).
LC3 puncta investigation
SW480 cells were transiently transfected with pEGFP-LC3
plasmid (gifted by Dr N. Mizushima, Tokyo Medical and
Dental University, Japan) by Lipofectamine 2000 (Invi-
trogen), and observed under a florescence microscope (DP
70; Olympus, Tokyo, Japan). Data were compared by
analysis of variance and Student t-test.
Results
miR-338-5p and its target gene PIK3C3 are
correlated with metastasis of the CRC specimens
RT-PCR results of the tumor tissues showed that miR-338-5p
was upregulated with an increase of stage and metastasis
status of the CRC specimens and positively correlated with
the stage and metastasis status of the CRC specimens
(p Z 0.0203). We further predicted the target genes of
miR-338-5p using TARGET SCAN, micrRNA.ORG, and DIANA
LAB target gene research software. Our data showed that
PIK3C3 mRNA expression was downregulated in metastatic
CRC specimens (p Z 0.0414) and inversely correlated with
miR-338-5p expression. This result indicates that PIK3C3
may be the target gene of miR-338-5p.
miR-338-5p induces CRC cell migration
The clinical data showed that miR-338-5p overexpression
correlates with the metastatic status of CRC patients. It is
known that high migration activity of cancer cell correlates
with metastasis.15 Our data showed that miR-338-5p
expression positively correlates with cell migration activ-
ity of CRC cells SW480, SW620, HCT-116, and HT29 by
wound-healing assay. When miR-338-5p mimic was trans-
fected into HCT-116 or SW480 CRC cells, the migration
ability was significantly increased by wound-healing assay
(pZ 0.08, pZ 0.0142). Furthermore, the migration ability
of SW480 cells was downregulated by miR-338-5p inhibitor(anti-miR-338-5p; pZ 0.0004; Table 1). In the ECIS assay, a
high impedance value was detected by miR-338-5p over-
expression, and increased migration ability of HCT-116
cells. Moreover, a low impedance value was detected by
low miR-338-5p expression. Furthermore, MTT assay results
showed that miR-338-5p overexpression could not induce
HCT-116 proliferation. Overall, our data suggest that miR-
338-5p induces CRC cell migration, but has no effect on
cell proliferation.
PIK3C3 is the target gene of miR-338-5p in CRC
To determine whether PIK3C3 is a target gene of miR-338-5,
miR-338-5p mimic and p-miR-PIK3C3-30-UTR-luciferase
plasmid were transfected into SW480 cells. Our result
showed that miR-338-5p overexpression significantly
decreased luciferase activity (p Z 0.002). Furthermore,
when miR-338-5p mimic was transfected into HCT-116 and
SW480 cells, and miR-338-5p inhibitor was transfected into
SW480 cells, the target gene PIK3C3 mRNA expression was
measured by RT-PCR. Our results showed that miR-338-5p
overexpression inhibited PIK3C3 RNA expression. Similarly,
miR-338-5p downregulation increased PIK3C3 RNA expres-
sion (Table 1). These results demonstrated that PIK3C3 is a
target gene of miR-338-5p.
miR-338-5p suppresses PIK3C3 and leads to
suppression of autophagy
To clarify the suppressive effect ofmiR-338-5p onPIK3C3 and
downregulation of autophagy pathway, the expression of
PIK3C3 and LC3 protein was evaluated by Western blotting.
PIK3C3 and LC3 type II were downregulated by miR-338-5p
overexpression, and upregulated by anti-miR-338-5p in HCT-
116 and SW480 cells. When miR-338-5p mimic and pGFP-LC3
plasmid were transfected into SW480 cells, the amount of
GFP-LC3 puncta was decreased (p Z 0.0005). By contrast,
Figure 1 Schematic hypothesis that miR-338-5p induces CRC cell migration by suppression of PIK3C3 and autophagy.
AATKZ apoptosis-associated tyrosine kinase; CRCZ colorectal cancer; mRNAZmessenger RNA; PIK3C3Z phosphatidylinositol 3-
kinase catalytic subunit type 3.
Colorectal cancer migration and autophagy-related microRNA 77miR-338-5p inhibitor increased the ratio of GFP-LC3 puncta
(pZ 0.0008; Table 1). Furthermore, our study clarified that
autophagy inhibits colon cancer cellmigration. Furthermore,
HCT-116 cells were treatedwith rapamycin (50 nM) to induce
autophagy. Cell migration was assayed by ECIS. We demon-
strated that rapamycin-induced autophagy inhibits colon
cancer cell migration. Taken together, our results suggest
that mir-338-5p inhibits LC3 puncta formation and represses
PIK3C3 and LC3II. The results also demonstrate that auto-
phagy may inhibit colon cancer cell migration.Discussion
The miR-338 stem loop has two miRNAs (miR-338-3p and
miR-338-5p). miR-338 is upregulated in the CRC, squamous
cell carcinoma, and metastatic hepatocellular
carcinoma.16e18 In our study, miR-338-5p is upregulated,
and its target gene PIK3C3 is downregulated in the meta-
static CRC patients. Consistent with our findings, a previous
study on CRC patients reported that miR-338-5p expression
showed positive correlation with stages in the serum of the
patients studied.9
miR-338-5p can induce CRC cell migration, and its target
gene is PIK3C3. Moreover, PIK3C3 forms multiple complexes
to regulate autophagy.19 Autophagy-related protein ATG5 is
strongly downregulated in CRC clinical tissues.20 Further-
more, PIK3C3 inhibits epithelialemesenchymal transition
(EMT) pathway by regulating autophagy to degrade snail and
twist, and affects breast cancermigration, tumor formation,
and metastasis.21 Autophagy induced by overexpressed
beclin-1 inhibits vascular endothelial growth factor and
matrixmetallopeptidase 9 expression, as well as suppression
of cervical cancer proliferation, migration, and invasion.14
miR-338-5p is located in an intronic region within the
gene for AATK.6 miR-338-5p cleaves PIK3C3 mRNA and in-
hibits autophagosome membrane nucleation. Autophagy
may degrade migration-related factors, that is, autophagyinhibits the pathway by degrading snail and twist that af-
fects breast cancer cell migration.21
Based on our study, we hypothesized that miR-338-5p
suppresses its target genes PIK3C3, which further inhibits
the autophagy pathway, and finally leads to increased
migration and metastasis ability of the CRC cells (Fig. 1).References
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